CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse events tied to blockbuster diabetes and weight-loss medications during an open ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback